The chimpanzee and other non-human-primate models in HIV-1 vaccine research

Trends in Microbiology

Volumn 8, Issue 9, 2000, Pages 426-431

  Nath, Brett M ^a   Schumann, Kristen E ^a   Boyer, Jean D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL MODEL; ANIMAL WELFARE; CHIMPANZEE; COMPARATIVE STUDY; DRUG COST; DRUG RESEARCH; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SAFETY; SIMIAN IMMUNODEFICIENCY VIRUS; SPECIES DIFFERENCE; VIRUS PATHOGENESIS;

AIDS VACCINES; ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; MACACA; PAN TROGLODYTES; PRIMATES; RESEARCH; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; PAN TROGLODYTES; PRIMATES; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034283220     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(00)01816-3     Document Type: Review

References (37)

1. Littlewood, J. and Barrowcliffe, T. (1987) The development and characterisation of antibodies to human factor VIII in haemophilic dogs. Thrombosis and Haemostasis 57, 314-321
2. Monahan, P. et al. (1998) Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther. 5, 40-49
3. Boyer, J. et al. (1997) Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 5, 526-532
4. Fultz, P. et al. (1992) Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256, 1687-1690
5. Girard, M. et al. (1991) Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl. Acad. Sci. U. S. A. 88, 542-546
6. Berthelot, P. et al. (1984) Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results. J. Med. Prim. 13, 119-133
7. Goodall, J. (1998) Essays on science and society: learning from the chimpanzees: a message humans can understand. Science 282, 2184-2185
8. Gao, F. et al. (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436-441
9. Fultz, P. et al. (1989) HIV infection of chimpanzees as a model for testing chemotherapeutics. Intervirology 30, 51-58
10. Novembre, F. et al. (1997) Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J. Virol, 71, 4086-4091
11. Kestens, L. et al. (1995) Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection. J. Infect. Dis. 172, 957-963
12. Ferrari, G. et al. (1993) The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees. AIDS Res. Hum. Retroviruses 9, 647-656
13. Mwaengo, D. and Novembre, F. (1998) Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections. J. Virol. 72, 8976-898
14. Letvin, N. and Prince, A. (1998) AIDS vaccine trials in chimpanzees. Science 282, 2194
15. Bagarazzi, M. et al. (1999) Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees. J. Infect. Dis. 180, 1351-1355
16. Robert-Guroff, M. et al. (1998) Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus. J. Virol. 72, 10275-10280
17. Edinger, A. et al. (1997) Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proc. Natl. Acad. Sci. U. S. A. 94, 4005-4010
18. Rudensey, L. et al. (1998) Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVmne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity or CCR-5 coreceptor recognition. J. Virol. 72, 209-217
19. Doms, R. et al. (1998) Coreceptor use by primate lentiviruses. In Human Retroviruses and AIDS (Korber, B. et al., eds), pp. 20-35, Theoretical Biology and Biophysics, Los Alamos National Laboratory
20. Rowland-Jones, S. et al. (1993) HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341, 860-861
21. Rowland-Jones, S. et al (1995) HIV-specific T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1, 59-64
22. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type-1 infection. J. Virol. 68, 6103-6110
23. Schmitz, J.E. et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8 lymphocytes. Science 283, 857-860
24. Kimata, J.T. et al. (1999) Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat. Med. 5, 535-541
25. Zhang, Z.Q. et al. (1999) Sexual transmission and propagation of SIV/HIV in resting and activated CD4 T cells. Science 286, 1353-1357
26. Kuwata, T. et al. (1996) Chimeric viruses between SIVmac and various HIV-1 isolates have biological properties that are similar to those of the parental HIV-1. AIDS 10, 1331-1337
27. Cayabyab, M. et al. (1999) Changes in human immunodeficiency virus type-1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus. J. Virol. 73, 976-984
28. Reimann, K.A. et al. (1999) Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses. Virology 256, 15-21
29. Lu, Y. et al. (1996) Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J. AIDS 12, 99-106
30. Pauza, C. et al. (2000) Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Natl. Acad. Sci. U. S. A. 97, 3515-3519
31. Mascola, J. et al. (1999) Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73, 4009-4018
32. Stott, E.J. et al. (1998) Evaluation of candidate human immunodeficiency virus type-1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous SIV/HIV-1 chimeric virus. J. Gen. Virol. 79, 423-432
33. Joag, S.V. et al. (1998) Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS. J. Virol. 72, 9069-9078
34. Kim, H. et al. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89, 422-434
35. Kim, H. et al. (1971) Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Peds. 48, 745-755
36. Jin, M.J. et al. (1994) Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J. Virol. 68, 8454-8460
37. Allan, J.S. et al. (1995) Infection of baboons with simian/human immunodeficiency viruses. J. AIDS 9, 429-441